Adeno-associated virus liver transduction efficiency measured by in vivo [ 18F]FHBG positron emission tomography imaging in rodents and nonhuman primates

Human Gene Therapy

Volumn 22, Issue 8, 2011, Pages 999-1009

  Pañeda, Astrid ^a   Collantes, Maria ^a   Beattie, Stuart G ^b   Otano, Itzia ^a   Snapper, Jolanda ^b   Timmermans, Eric ^b   Guembe, Laura ^a   Petry, Harald ^b   Lanciego, Jose Luis ^a   Benito, Alberto ^c   Prieto, Jesus ^a,c   Rodriguez Pena, Maria Sol ^b   Peñuelas, Iván ^a,c   Gonzalez Aseguinolaza, Gloria ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Amsterdam Molecular Therapeutics   (Netherlands)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

9 [4 FLUORO 3 (HYDROXYMETHYL)BUTYL]GUANINE F 18; GAMMA INTERFERON; LUCIFERASE; PARVOVIRUS VECTOR; THYMIDINE KINASE; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER; LOW DRUG DOSE; MACACA FASCICULARIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; POSITRON EMISSION TOMOGRAPHY; RAT; REPORTER GENE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPECIES DIFFERENCE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

ANIMALS; DEPENDOVIRUS; FEMALE; FLUORINE RADIOISOTOPES; GENES, REPORTER; GENETIC VECTORS; GUANINE; LIVER; MACACA FASCICULARIS; MALE; MICE; MICE, INBRED C57BL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSGENES;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS - 5; ANIMALIA; PRIMATES; RODENTIA; SIMPLEXVIRUS;

EID: 80051983085     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.190     Document Type: Article

References (44)

1. Alexander, I.E., Cunningham, S.C., Logan, G.J., and Christo-doulou, J. (2008). Potential of AAV vectors in the treatment of metabolic disease. Gene Ther. 15, 831-839. (Pubitemid 351712616)
2. Boutin, S., Monteilhet, V., Veron, P., et al. (2010). Prevalence of serum IgG and neutralizing factors against adeno-associated virus types 1, 2, 5, 6, 8 and 9 in the healthy population: Implications for gene therapy using AAV vectors. Hum. Gene Ther. 21, 704-712.
3. Cherry, S.R. (2009). Multimodality imaging: Beyond PET/CT and SPECT/CT. Semin. Nucl. Med. 39, 348-353.
4. Davidoff, A.M., Gray, J.T., Ng, C.Y., et al. (2005). Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Mol. Ther. 11, 875-888. (Pubitemid 40724106)
5. Daya, S., and Berns, K.I. (2008). Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 4, 583-593.
6. Del Guerra, A., and Belcari, N. (2002). Advances in animal PET scanners. Q. J. Nucl. Med. 46, 35-47. (Pubitemid 34808737)
7. Di Pasquale, G., Davidson, B.L., Stein, C.S., et al. (2003). Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9, 1306-1312. (Pubitemid 37279855)
8. Fontanellas, A., Hervas-Stubbs, S., Sampedro, A., et al. (2009). PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector. Gene Ther. 16, 136-141.
9. Gambhir, S.S., Barrio, J.R., Phelps, M.E., et al. (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. U.S.A. 96, 2333-2338. (Pubitemid 29117915)
10. Gao, G., Vandenberghe, L.H., Alvira, M.R., et al. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. (Pubitemid 38715936)
11. Gao, G., Lu, Y., Calcedo, R., et al. (2006). Biology of AAV sero-type vectors in liver-directed gene transfer to nonhuman primates. Mol. Ther. 13, 77-87. (Pubitemid 41763485)
12. Gao, G., Wang, Q., Calcedo, R., et al. (2009). Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses. Hum. Gene Ther. 20, 930-942.
13. Gao, G.P., Lu, Y., Sun, X., et al. (2006). High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes. J. Virol. 80, 6192-6194. (Pubitemid 43849199)
14. Grieger, J.C., and Samulski, R.J. (2005). Adeno-associated virus as a gene therapy vector: Vector development, production and clinical applications. Adv. Biochem. Eng. Biotechnol. 99, 119-145. (Pubitemid 44617179)
15. Hermens, W.T., ter Brake, O., Dijkhuizen, P.A., et al. (1999). Purification of recombinant adeno-associated virus by iodix-anol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum. Gene Ther. 10, 1885-1891. (Pubitemid 29357694)
16. Jiang, H., Couto, L.B., Patarroyo-White, S., et al. (2006). Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood 108, 3321-3328.
17. Kramer, M.G., Barajas, M., Razquin, N., et al. (2003). In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol. Ther. 7, 375-385. (Pubitemid 36503861)
18. Liang, Q., Gotts, J., Satyamurthy, N., et al. (2002). Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. Mol. Ther. 6, 73-82. (Pubitemid 36124273)
19. Luebke, A.E., Rova, C., Von Doersten, P.G., and Poulsen, D.J. (2009). Adenoviral and AAV-mediated gene transfer to the inner ear: Role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies. Adv. Otorhinolaryngol. 66, 87-98.
20. Manno, C.S., Pierce, G.F., Arruda, V.R., et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347. (Pubitemid 43355084)
21. Markakis, E.A., Vives, K.P., Bober, J., et al. (2010). Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. Mol. Ther. 18, 588-593.
22. Mercier-Letondal, P., Deschamps, M., Sauce, D., et al. (2008). Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: An altered immune response? Hum. Gene Ther. 19, 937-950.
23. Miao, C.H., Nakai, H., Thompson, A.R., et al. (2000). Non-random transduction of recombinant adeno-associated viral vectors in mouse hepatocytes in vivo: Cell cycle does not influence hepatocytes transduction. J. Virol. 74, 3793-3803. (Pubitemid 30180322)
24. Mueller, C., and Flotte, T.R. (2008). Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15, 858-863. (Pubitemid 351712619)
25. Murphy, S.L., Li, H., Zhou, S., et al. (2008). Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver. Mol. Ther. 16, 138-145.
26. Nakai, H., Thomas, C.E., Storm, T.A., et al. (2002). A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J. Virol. 76, 11343-11349. (Pubitemid 35231289)
27. Nathwani, A.C., Davidoff, A.M., Hanawa, H., et al. (2002). Sustained high-level expression of human factor IX(hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 100, 1662-1669. (Pubitemid 34925143)
28. Nathwani, A.C., Gray, J.T., Ng, C.Y., et al. (2006). Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107, 2653-2661.
29. Nathwani, A.C., Gray, J.T., McIntosh, J., et al. (2007). Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood 109, 1414-1421. (Pubitemid 46239572)
30. Pañeda, A., Beattie, S.G., Otano, I., Aurrekoetrea, I., Petry, H., Lanciego, J.L., Benito, A., Prieto, J., Gonzalez-Aseguinolaza, G. Unpublished observations.
31. Pañeda, A., Vanrell, L., Mauleon, I., et al. (2009). Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Hum. Gene Ther. 20, 908-917.
32. Peden, C.S., Burger, C., Muzyczka, N., and Mandel, R.J. (2004). Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J. Virol. 78, 6344-6359. (Pubitemid 38715933)
33. Peñ uelas, I., Boán, J.F., Martí-Climent, J.M., et al. (2002). A fully automated one pot synthesis of 9-(4-[18F]fluoro-3-hydro- xymethylbutyl) guanine for gene therapy studies. Mol. Imaging Biol. 4, 415-424. (Pubitemid 36221809)
34. Peñ uelas, I., Haberkorn, U., Yaghoubi, S., and Gambhir, S.S. (2005a). Gene therapy imaging in patients for oncological applications. Eur. J. Nucl. Med. Mol. Imaging 32, S384-S403. (Pubitemid 41796402)
35. Peñuelas, I., Mazzolini, G., Boán, J.F., et al., 2005b, Positron emission tomography imaging of adenoviral-mediated trans-gene expression in liver cancer patients. Gastroenterology, 128, 1787-1795. (Pubitemid 40824689)
36. Rivière, C., Danos, O., and Douar, A.M. (2006). Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther. 13, 1300-1308. (Pubitemid 44264084)
37. Stieger, K., Lhériteau, E., Moullier, P., and Rolling, F. (2009). AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J. 50, 206-224.
38. Terzi, D., and Zachariou, V. (2008). Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders. Biotechnol. J. 12, 1555-1563.
39. Urabe, M., Nakakura, T., Xin, K.Q., et al. (2006). Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J. Virol. 80, 1874-1885. (Pubitemid 43228727)
40. Waerzeggers, Y., Monfared, P., Viel, T., et al. (2009). Methods to monitor gene therapy with molecular imaging. Methods 48, 146-160.
41. Wang, L., Calcedo, R., Wang, H., et al. (2010). The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques. Mol. Ther. 18, 126-134.
42. Willmann, J.K., van Bruggen, N., Dinkelborg, L.M., and Gamb-hir, S.S. (2008). Molecular imaging in drug development. Nat. Rev. Drug Discov. 7, 591-607. (Pubitemid 351927724)
43. Yaghoubi, S.S., and Gambhir, S.S. (2006). PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant. HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat. Protoc. 1, 3069-3075.
44. Zolotukhin, S., Byrne, B.J., Mason, E., et al. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titre and yield. Gene Ther. 6, 973-985. (Pubitemid 29295202)